Address: | 840 Research Pkwy, Oklahoma City, OK 73104, USA |
---|---|
Postal code: | 73104 |
Phone: | (405) 271-1469 |
Website: | http://www.tetherex.com/contact.html |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Tetherex Pharmaceuticals, use the form below and your opinion, advice or comment will appear in this space.
Corporate Headquarters 840 Research Parkway, Suite 516 Oklahoma City, OK 73104 (405) 271-1469 - Main Phone (405) 319-8197 - Fax info at tetherex dot com. Research Triangle Park Office 3800 Paramount Parkway, Suite 130 Morrisville, NC 27567 info at tetherex dot com.
Tetherex's top competitors are Regulus, Portola and Momenta. Tetherex Pharmaceuticals focuses on the development of novel selectin inhibitor products to treat thrombosis, inflammatory diseases and cancer. Oklahoma City, Oklahoma73104. 405-271-1469.
Tetherex Pharmaceuticals is developing novel products to treat thrombosis inflamatory disease and cancer. Its lead clinical program is focused on an antibody names SelK2 initally under development for the treat of venous thromboembolism and Crohn's desease. Year Founded: 2014.
(405) 319-8195. Tetherex Pharmaceuticals operates in the healthcare industry focusing on biotechnology business. The company was incorporated in 2014 and is based in Oklahoma City, Oklahoma.
To explore Tetherex Pharmaceuticals's full profile, request a free trial. Tetherex Pharmaceuticals Valuation and Funding. Deal Type. Rodger McEver MD. Tetherex Pharmaceuticals. Co-Founder & Board Member. 000 0000. Scott Rollins Ph.D. Tetherex Pharmaceuticals.
Tetherex pharmaceuticals corporation. Address. 840 research pkwy,ste 516. Tetherex Pharmaceuticals Corporation. Trade Name ("Doing Business As ...") Phone Number: 405-206-7843.
Tetherex Pharmaceuticals Corp is a clinical-stage development biopharmaceutical company focused on development of therapeutics for the treatment of inflamm. Phone: 405-319-8195. Date of Last Funding. Tetherex Pharmaceuticals Corp. $55.3M.
Tetherex Pharmaceuticals is developing monoclonal antibody-based therapeutics for the treatment of inflammatory diseases. The company's lead product candidate SelK2 is a humanized monoclonal Tetherex Pharmaceuticals Overview. Founded Year2014. LocationOklahoma City, United States.
Tetherex Pharmaceuticals Corp Funding details. Tetherex Pharmaceuticals Corp Industry: Biotechnology CIK Number: 0001634581 IRS Number: 472273579 Address: 840 RESEARCH PARKWAY, SUITE 516 OKLAHOMA CITY 73104 Phone number: 405-319-8195.
BioPharmGuy data on file for Tetherex Pharmaceuticals. Tetherex Pharmaceuticals. Founded 2014; Website.